Hssd

What happens when women have to fight to be heard in medicine? In this episode, we’re breaking down The Pink Pill — a powerful documentary that follows the long, complicated journey of getting Addyi (flibanserin) approved for women with low sexual desire.We talk about: the fight behind FDA...

Key Takeaways

* Medherant’s patch could become the first-in-class testosterone patch developed specifically for women.  Built on the company’s proprietary TEPI Patch technology, it provides exceptional adhesion, ensuring reliable and comfortable wear throughout daily activities.  * David Haddleton, Chief...

Dr. Sheryl Kingsberg discusses the most prevalent sexual health concern for women of all ages (HSDD). She offers tips on how to open the discussion, reviews the various screening tools, and outlines the treatment options.

* We demonstrate the clinical potential for intranasal kisspeptin delivery as the first non-invasive method to robustly and safely stimulate gonadotropins with kisspeptin and potentially transform the management of reproductive disorders. * In summary, we provide the first human evidence...

https://www.endocrine-abstracts.org/ea/0109/ea0109p341 Introduction HSDD is characterized by long-term decrease in sexual desire (low-libido) causing personal distress. HSDD predominantly affects postmenopausal women or following oophorectomy. Despite the clear indication that testosterone...

https://www.endocrine-abstracts.org/ea/0094/ea0094oc4.4 Background Kisspeptin is a potent regulator of GnRH neurons with the potential to treat reproductive and psychosexual disorders. However, administration is limited to the subcutaneous or intravenous routes. These invasive routes limit...

What are common misunderstandings about female sexual medicine for clinicians? What are common misunderstandings about female sexual medicine for patients? What one message would you want to get across to women suffering from low sexual desire? What is the most exciting new thing related...

Presentation by Dr. Shelly Varod at the ESSM 2023 congress round table: Hypoactive Sexual Desire in Young Women: What Women Want Dr. Varod is a clinical psychologist and certified sex therapist at the Reut Rehabilitation Hospital in Tel Aviv, Israel. She is active in the Israel Society for...

Have you heard of Bremelanotide or PT-141? Does it work for premenopausal women only? Or is this amazing new drug a new option for erectile dysfunction and low libido for men? Watch the video till the end and let me know your thoughts in the comments. Thanks for watching!! ▶️Chapters...

What is kisspeptin and why are men using it? ExcelMale's guide covers how kisspeptin works, reported benefits for testosterone and libido, and dosing protocols. Novel therapeutic avenues for kisspeptin (2022) Jovanna Tsoutsoukia, Ali Abbarab, and Waljit Dhillo Abstract Kisspeptin is a...

The clinical management of testosterone replacement therapy in postmenopausal women with hypoactive sexual desire disorder: a review (2022) Maria Uloko✉, Farah Rahman , Leah Ibrahim Puri and Rachel S. Rubin As women age, there is an overall decrease in androgen production due to a decline in...

NAMS PRACTICE PEARL Clinical management of hypoactive sexual desire disorder in postmenopausal women (2022) Sheryl A. Kingsberg, PhD, and Stephanie S. Faubion, MD, MBA, FACP, NCMP, IF Approximately 10% to 12% of women meet the criteria for hypoactive sexual desire disorder, with the highest...

Pharmacotherapy for female sexual dysfunctions (FSDs): what is on the market and where is this field heading? (2022) Rossella E. Nappi, Lara Tiranini, Laura Cucinella, Ellis Martini, David Bosoni, Alessandra Righi, Chiara Cassani, and Barbara Gardella ABSTRACT Introduction: Female sexual...

Medical Treatment of Female Sexual Dysfunction (2022) Rossella E. Nappi, MD, PhD, Lara Tiranini, MD, Ellis Martini, MD, David Bosoni, MD, Alessandra Righi, MD, Laura Cucinella, MD INTRODUCTION A sexual problem associated with personal distress in women qualifies as a female sexual dysfunction...

https://www.urologytimes.com/view/urology-times-50-innovations-series-treatment-of-female-hypoactive-sexual-desire-disorder Urology Times® is celebrating its 50th anniversary in 2022. To mark the occasion, we are highlighting 50 of the top innovations and developments that have transformed the...

Androgen Therapy in Women with Testosterone Insufficiency: Looking Back and Looking Ahead (2022) Abdulmaged M. Traish and Abraham Morgentaler Abstract In women, androgens not only serve as precursors for the biosynthesis of estrogens but also exert a critical physiological role in sexual...

The Potential for Pharmacological Interventions for Low Sex Drive in Men (2021) Amit G. Reddy, MD,1 Amelia A. Khoei, BS,2 and Mohit Khera, MD1 NTRODUCTION Despite numerous advancements in the field of sexual medicine, there remain a handful of conditions that are difficult to characterize...